| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/19/2008 | CN101146530A 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 03/19/2008 | CN101146529A Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 03/19/2008 | CN101146528A Pharmaceutical composition comprising hydroxylated nebivolol |
| 03/19/2008 | CN101146527A Methods for QT interval control |
| 03/19/2008 | CN101146526A Anti-microbial agent |
| 03/19/2008 | CN101146525A Use of lactobacillus rhamnosus gg in combination with a long chain polyunsaturated fatty acid for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant |
| 03/19/2008 | CN101146523A Transdermal delivery systems |
| 03/19/2008 | CN101146520A Delayed release formulations of 6-mercaptopurine |
| 03/19/2008 | CN101146519A Solid oral dosage form of valopi citabine (VAL-MCYD) and method of preparing it |
| 03/19/2008 | CN101146517A Methods and systems for operating an aerosol generator |
| 03/19/2008 | CN101146516A Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 03/19/2008 | CN101146508A Cosmetic and cosmeceutical compositions for restoration of skin barrier function |
| 03/19/2008 | CN101144081A Nucleic acid molecule TRAIL and application in preparation of anti-tumour pharmaceutical |
| 03/19/2008 | CN101143926A Polyamide micro-particle and preparation method thereof |
| 03/19/2008 | CN101143905A Green extraction method for gelose |
| 03/19/2008 | CN101143892A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 03/19/2008 | CN101143885A Glucocorticoids derivative, preparation method and application thereof |
| 03/19/2008 | CN101143882A Tyrosinase activity cntrolling agent, process for producing the same and external preparations containing the same |
| 03/19/2008 | CN101143872A 3-halogen substituted cephalosporin derivative |
| 03/19/2008 | CN101143871A 头孢菌素衍生物 Cephalosporin derivatives |
| 03/19/2008 | CN101143870A Novel cephalosporin derivative |
| 03/19/2008 | CN101143869A Aldose reductase inhibitor structure and synthesis method thereof |
| 03/19/2008 | CN101143868A Aldose reductase inhibitor structure and use |
| 03/19/2008 | CN101143867A Antidepressant indolealkyl derivatves of heterocyclefused benzodioxan methylamines |
| 03/19/2008 | CN101143866A Chlorophyll derivatives, preparation method and application thereof in medical agricultural chemicals |
| 03/19/2008 | CN101143861A B ring 4'-single substituted flavone compounds, preparation method and use |
| 03/19/2008 | CN101143859A Novel compound, its synthesis method and therapeutical uses |
| 03/19/2008 | CN101143857A Benzoyl guanidine derivative, preparation method and medical use thereof |
| 03/19/2008 | CN101143853A Biphenyltetrazoles compounds and preparation method thereof |
| 03/19/2008 | CN101143851A Ligustrazine aromatic acid ether derivatives, preparation method thereof, medicament composition and use |
| 03/19/2008 | CN101143846A Metal salt of quinaprilat |
| 03/19/2008 | CN101143845A Substituted quinoline formyl guanidine derivative, its preparation method and medical use |
| 03/19/2008 | CN101143834A Polymorphism for N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide sodium salt and preparation method thereof |
| 03/19/2008 | CN101143239A Medicinal controlled release catheter |
| 03/19/2008 | CN101143221A Central airway administration for systemic delivery of therapeutics |
| 03/19/2008 | CN101143220A Hydrogenated castor oil nano-lipophilic medicine preparation and preparation method thereof |
| 03/19/2008 | CN101143217A Treatment of neurological and neuropsychological disorders |
| 03/19/2008 | CN101143213A Male analeptic and preparing process thereof |
| 03/19/2008 | CN101143210A Compound fatty milk oral preparation |
| 03/19/2008 | CN101143192A Therapeutic gastrodia extracts |
| 03/19/2008 | CN101143185A Medicinal composition capable of anti-senility during menopausal syndrome |
| 03/19/2008 | CN101143181A Traditional Chinese medicinal composition for treating senile dementia and preparation method and application thereof |
| 03/19/2008 | CN101143173A Capsule for treating acute dysentery and acute diarrhea and its preparation method |
| 03/19/2008 | CN101143172A Traditional Chinese medicine for treating obesity in children |
| 03/19/2008 | CN101143166A Medicine for swelling and relieving pain and its preparation method and application |
| 03/19/2008 | CN101143165A Composition containing cistanche tubulosa and its extract for treating osteoporosis |
| 03/19/2008 | CN101143160A Kidney tea extract and its preparing process and application |
| 03/19/2008 | CN101143156A External-applied traditional Chinese medicine preparation for treating scald |
| 03/19/2008 | CN101143150A External-applied medicine for treating condyloma acuminata |
| 03/19/2008 | CN101143149A Compound extracting and separating method and its application as medicine |
| 03/19/2008 | CN101143148A Application of paris saponin I and its derivatives |
| 03/19/2008 | CN101143147A Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 03/19/2008 | CN101143146A Cefoperazone sodium and sulbactam sodium composition |
| 03/19/2008 | CN101143145A Tadalafil chewing gum and manufacturing method and application |
| 03/19/2008 | CN101143144A Milrinone lactate freezing-dried powder injection and preparation method thereof |
| 03/19/2008 | CN101143143A Medicine for treating gastroesophageal reflux disease and functional dyspepsia |
| 03/19/2008 | CN101143142A Silybin supersaturated self-emulsion composition and preparation method thereof |
| 03/19/2008 | CN101143141A Baicalein or scutellarein and doxifluridine combined |
| 03/19/2008 | CN101143140A Isosorbide mononitrate timely quick-release and slow-release preparation |
| 03/19/2008 | CN101143139A Stable tiopronin injection and preparation method thereof |
| 03/19/2008 | CN101143138A Paracetamol and pseudoephedrine hydrochloride tablets made by dry powder direct tabletting |
| 03/19/2008 | CN101143136A Paroxetine slow release micropills preparation |
| 03/19/2008 | CN101143135A Melatonin orally disintegrating tablet and preparation method thereof |
| 03/19/2008 | CN101143134A Dexrazoxane freezing-dried powder injection and preparation method thereof |
| 03/19/2008 | CN101143133A Sodium fusidate freezing-dried powder injection |
| 03/19/2008 | CN101143132A Method for preparing high content beta-carotene water soluble nanometer particles |
| 03/19/2008 | CN101143130A Carmustine intravenous emulsion and its preparation method |
| 03/19/2008 | CN101143129A Methotrexate intravenous emulsion and its preparation method |
| 03/19/2008 | CN101143127A Phentolamine external-applied preparation and its preparation method |
| 03/19/2008 | CN101143011A Method for improving iron bioavailability in food |
| 03/19/2008 | CN100375785C Clone, expression and anti-tick immanoprotection action of falcate rhipicephalus RhcA and RhcB genes |
| 03/19/2008 | CN100375755C Longleaf Grateloupia acuminata polysaccharide extract and its preparation and use |
| 03/19/2008 | CN100375752C Oleanolic acid and its derivative, preparation method and use |
| 03/19/2008 | CN100375750C Oligopolynucleotide of inhibiting activity of necrosin in human tumor |
| 03/19/2008 | CN100375742C 4-oxoquinoline compounds and its use |
| 03/19/2008 | CN100375635C Water soluble anti-cancer medicine slow-release fiber preparation and preparing method therefor |
| 03/19/2008 | CN100375631C Chinese traditional medicine composition for relieving side effects of hormones |
| 03/19/2008 | CN100375626C Chinese medicine compound preparation for treating depression and its preparation method |
| 03/19/2008 | CN100375625C Quick thrombolysis for apoplexy |
| 03/19/2008 | CN100375624C Method and device for high efficiency separation of puerarin |
| 03/19/2008 | CN100375623C Compound medicine for treating meat chicken ascites |
| 03/19/2008 | CN100375622C Freeze dried powder injection of cytarabine and its preparation process |
| 03/19/2008 | CN100375621C Vinorelbine liposome micro ball injection and its preparation method |
| 03/19/2008 | CN100375620C Application of monomer ingredient jatrorrhizine of Chinese goldthread in preparation of medicine for enhancing stomach motility |
| 03/19/2008 | CN100375619C Medicinal compositions improving brain function and method for improving brain function |
| 03/19/2008 | CN100375615C Compound drop pills of stramonium and its preparation method |
| 03/19/2008 | CN100375612C Blood pressure lowering dripping pills with chryanthemum flower and pearl and its preparation process |
| 03/19/2008 | CN100375609C Dripping pills of emblic leafflower fruit and its preparation process |
| 03/18/2008 | USRE40155 Methods for treatment of benign and malignant tumors, including lymphomas, leukemias, and leiomyomas |
| 03/18/2008 | US7345190 Improved lipophilicity, toxicity, bioavailability, and pharmacokinetics; for treatment of cardiovascular and neurological disorders |
| 03/18/2008 | US7345181 Process for preparing prostaglandin derivatives and starting materials for the same |
| 03/18/2008 | US7345175 Biphenyl derivatives |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345172 Intercalation compound for use in the diagnosis and detection of genetic disorders; sterically demanding nucleotide intercalating compounds and methods for detecting base pair mismatches in nucleic acid sequences |
| 03/18/2008 | US7345156 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345096 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 03/18/2008 | US7345095 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester |
| 03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 03/18/2008 | US7345093 Methods of enhancing solubility of compounds |